Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM2 | Q14416 | 2/20 | 0.33 |
| ▸ | GRM3 | Q14832 | 2/20 | 0.33 |
| ▸ | GRM4 | Q14833 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | GRM8 | O00222 | 1/20 | 0.33 |
| ▸ | GRM6 | O15303 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | GRM5 | P41594 | 1/20 | 0.33 |
| ▸ | MTOR | P42345 | 1/20 | 0.33 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.33 |
| ▸ | PLCB1 | Q9NQ66 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.31 |
| ▸ | ANPEP | P15144 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8768564 | 0.77 | RAB9A (0.31) | — | |
| SCHEMBL2229712 | 0.74 | CA2 (0.32) | TDP1TSHR | |
| SCHEMBL2232012 | 0.73 | — | — | |
| SCHEMBL20335205 | 0.72 | GRM2 (0.36) | GRM2GRM3GRM4CYP1A2ALOX15 | |
| SCHEMBL10975483 | 0.72 | GRM2 (0.36) | GRM2GRM3GRM4CYP1A2ALOX15 | |
| SCHEMBL2232013 | 0.71 | ARG1 (0.32) | POLB | |
| SCHEMBL2229558 | 0.70 | ARG1 (0.31) | POLB | |
| SCHEMBL2228233 | 0.70 | ARG1 (0.31) | POLB | |
| SCHEMBL25272770 | 0.69 | CYP2C19 (0.39) | GRM2GRM3GRM4CYP1A2ALOX15 | |
| SCHEMBL30538381 | 0.69 | CA2 (0.32) | TDP1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8299292-B2 | Method of preparing of 60% or more CIS-DI(C4-C20)alkyl cyclohexane-1,4-dicarboxylate | HANWHA CHEMICAL CORPORATION (KR) | 2012-10-30 | — | — | US | claimed |
| US-20110263770-A1 | Method of Preparing of 60% or More CIS-DI(C4-C20)Alkyl Cyclohexane-1,4-Dicarboxylate | HANWHA CHEMICAL CORPORATION (KR) | 2011-10-27 | — | — | US | claimed |
| EP-2344443-A2 | METHOD OF PREPARING OF 60% OR MORE CIS-DI(C4-C20)ALKYL CYCLOHEXANE-1,4-DICARBOXYLATE | Hanwha Chemical Corporation (KR) | 2011-07-20 | — | — | EP | claimed |
| WO-2010044638-A2 | METHOD OF PREPARING OF 60% OR MORE CIS-DI(C4-C20)ALKYL CYCLOHEXANE-1,4-DICARBOXYLATE | HANWHA CHEMICAL CORPORATION (KR) | 2010-04-22 | — | — | WO | claimed |
| US-20130053492-A1 | Polyvinylchloride Composition with a DI(C4-C20)Alkyl Cyclohexane-1,4-Dicarboxylate Having High CIS Content | HANWHA CHEMICAL CORPORATION (KR) | 2013-02-28 | — | — | US | disclosed |
| US-8299292-B2 | Method of preparing of 60% or more CIS-DI(C4-C20)alkyl cyclohexane-1,4-dicarboxylate | HANWHA CHEMICAL CORPORATION (KR) | 2012-10-30 | — | — | US | disclosed |
| US-20110263770-A1 | Method of Preparing of 60% or More CIS-DI(C4-C20)Alkyl Cyclohexane-1,4-Dicarboxylate | HANWHA CHEMICAL CORPORATION (KR) | 2011-10-27 | — | — | US | disclosed |
| EP-2344443-A2 | METHOD OF PREPARING OF 60% OR MORE CIS-DI(C4-C20)ALKYL CYCLOHEXANE-1,4-DICARBOXYLATE | Hanwha Chemical Corporation (KR) | 2011-07-20 | — | — | EP | disclosed |
| WO-2010044638-A2 | METHOD OF PREPARING OF 60% OR MORE CIS-DI(C4-C20)ALKYL CYCLOHEXANE-1,4-DICARBOXYLATE | HANWHA CHEMICAL CORPORATION (KR) | 2010-04-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110263770-A1 | Method of Preparing of 60% or More CIS-DI(C4-C20)Alkyl Cyclohexane-1,4-Dicarboxylate | ADH1A, ADH1C, DDT | GRM2 3827/4885GRM3 3648/4885GRM4 3290/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.